Jump to content

Benzalkonium chloride

From Wikipedia, the free encyclopedia
(Redirected from BAC 50)
Benzalkonium chloride
Names
Other names
N-Alkyl-N-benzyl-N,N-dimethylammonium chloride; Alkyldimethylbenzylammonium chloride; ADBAC; BC50 BC80
Identifiers
ChEBI
ChEMBL
EC Number
  • 264-151-6
KEGG
RTECS number
  • BO3150000
UNII
Properties
Variable
Molar mass Variable
Appearance
  • 100% is white or yellow powder; gelatinous lumps;
  • BC50 (50%) and BC80 (80%) solutions are colourless to pale yellow solutions.
Density 0.98 g/cm3
Very soluble
Pharmacology
D08AJ01 (WHO)
Hazards
GHS labelling:
GHS05: CorrosiveGHS07: Exclamation markGHS09: Environmental hazard
Danger
H302, H312, H314, H410
P260, P264, P270, P273, P280, P301+P312, P301+P330+P331, P302+P352, P303+P361+P353, P304+P340, P305+P351+P338, P310, P312, P321, P322, P330, P363, P391, P405, P501
NFPA 704 (fire diamond)
NFPA 704 four-colored diamondHealth 3: Short exposure could cause serious temporary or residual injury. E.g. chlorine gasFlammability 0: Will not burn. E.g. waterInstability 0: Normally stable, even under fire exposure conditions, and is not reactive with water. E.g. liquid nitrogenSpecial hazards (white): no code
3
0
0
Flash point 250 °C (482 °F; 523 K) (if solvent based)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

Benzalkonium chloride (BZK, BKC, BAK, BAC), also known as alkyldimethylbenzylammonium chloride (ADBAC) and by the trade name Zephiran,[1] is a type of cationic surfactant. It is an organic salt classified as a quaternary ammonium compound. ADBACs have three main categories of use: as a biocide, a cationic surfactant, and a phase transfer agent.[2] ADBACs are a mixture of alkylbenzyldimethylammonium chlorides, in which the alkyl group has various even-numbered alkyl chain lengths.

Solubility and physical properties

[edit]

Depending on purity, benzalkonium chloride ranges from colourless to a pale yellow (impure). Benzalkonium chloride is readily soluble in ethanol and acetone. Dissolution in water is ready, upon agitation. Aqueous solutions should be neutral to slightly alkaline. Solutions foam when shaken. Concentrated solutions have a bitter taste and a faint almond-like odour.[citation needed]

Standard concentrates are manufactured as 50% and 80% w/w solutions, and sold under trade names such as BC50, BC80, BAC50, BAC80, etc. The 50% solution is purely aqueous, while more concentrated solutions require incorporation of rheology modifiers (alcohols, polyethylene glycols, etc.) to prevent increases in viscosity or gel formation under low temperature conditions.

Cationic surfactant

[edit]

Benzalkonium chloride possesses surfactant properties, dissolving the lipid phase of the tear film and increasing drug penetration, making it a useful excipient, but at the risk of causing damage to the surface of the eye.[3]

  • Laundry detergents and treatments.
  • Softeners for textiles.

Phase transfer agent

[edit]
Main article: Phase transfer catalysis

Benzalkonium chloride is a mainstay of phase-transfer catalysis, an important technology in the synthesis of organic compounds, including drugs.[citation needed]

Bioactive agents

[edit]

Especially for its antimicrobial activity, benzalkonium chloride is an active ingredient in many consumer products:

Benzalkonium chloride is also used in many non-consumer processes and products, including as an active ingredient in surgical disinfection. A comprehensive list of uses includes industrial applications.[9]

During the course of the COVID-19 pandemic, from time to time there have been shortages of hand cleaner containing ethanol or isopropanol as active ingredients. The FDA has stated that benzalkonium chloride is eligible as an alternative for use in the formulation of healthcare personnel hand rubs.[10] However, in reference to the FDA rule, the CDC states that it does not have a recommended alternative to ethanol or isopropanol as active ingredients, and adds that "available evidence indicates benzalkonium chloride has less reliable activity against certain bacteria and viruses than either of the alcohols."[11] In November 2020 the Journal of Hospital Infection published a study on benzalkonium chloride formulations; it was found that laboratory and commercial disinfectants with as little as 0.13% benzalkonium chloride inactivated the SARS-CoV-2 virus within 15 seconds of contact, even in the presence of a soil or hard water.[12] This resulted in a growing consensus that BZK sanitizers are just as effective as alcohol-based sanitizers despite the CDC guidelines.[13] As a hand sanitizer, use of BZK may be advantageous over ethanol in some situations because it has significantly more residual antibacterial action on the skin after initial application.[14] Benzalkonium chloride has demonstrated persistent antimicrobial activity for up to four hours after contact whereas ethanol-based sanitizer demonstrate skin protection for only 10 minutes post-application.[15]

Medicine

[edit]

Benzalkonium chloride is a frequently used preservative in eye drops; typical concentrations range from 0.004% to 0.01%.[16] Stronger concentrations can be caustic[17] and cause irreversible damage to the corneal endothelium.[18]

Avoiding the use of benzalkonium chloride solutions while contact lenses are in place is discussed in the literature.[19][20]

Due to its antimicrobial activity[21] when applied to skin, some topical medications for acne vulgaris have benzalkonium chloride added to increase the products' efficiency or shelf-life.[22][23]

Benzalkonium chloride has also been shown to be a spermicide.[24] In Russia and China, benzalkonium chloride is used as a contraceptive. Tablets are inserted vaginally, or a gel is applied, resulting in local spermicidal contraception.[25][26] It is not a wholly reliable method, and can cause irritation.

Beekeeping

[edit]

This chemical is used in beekeeping for the treatment of rotten diseases of the brood.[27]

Adverse effects

[edit]

Although historically benzalkonium chloride has been ubiquitous as a preservative in ophthalmic preparations, its ocular toxicity and irritant properties,[28] in conjunction with consumer demand, have led pharmaceutical companies to increase production of preservative-free preparations, or to replace benzalkonium chloride with preservatives which are less harmful.[29]

Many mass-marketed inhaler and nasal spray formulations contain benzalkonium chloride as a preservative, despite substantial evidence that it can adversely affect ciliary motion, mucociliary clearance, nasal mucosal histology, human neutrophil function, and leukocyte response to local inflammation.[30] Although some studies have found no correlation between use of benzalkonium chloride in concentrations at or below 0.1% in nasal sprays and drug-induced rhinitis,[31] others have recommended that benzalkonium chloride in nasal sprays be avoided.[32][33] In the United States, nasal steroid preparations that are free of benzalkonium chloride include budesonide, triamcinolone acetonide, dexamethasone, and Beconase and Vancenase aerosol inhalers.[30]

Benzalkonium chloride is an irritant to middle ear tissues at typically used concentrations. Inner ear toxicity has been demonstrated.[34]

Occupational exposure to benzalkonium chloride has been linked to the development of asthma.[35] In 2011, a large clinical trial designed to evaluate the efficacy of hand sanitizers based on different active ingredients in preventing virus transmission amongst schoolchildren was re-designed to exclude sanitizers based on benzalkonium chloride due to safety concerns.[36]

Benzalkonium chloride has been in common use as a pharmaceutical preservative and antimicrobial since the 1940s. While early studies confirmed the corrosive and irritant properties of benzalkonium chloride, investigations into the adverse effects of, and disease states linked to, benzalkonium chloride have only surfaced during the past 30 years. [citation needed]

Toxicology

[edit]

RTECS lists the following acute toxicity data:[37]

Organism Route of exposure Dose (LD50)
Rat Intravenous 13.9 mg/kg
Rat Oral 240 mg/kg
Rat Intraperitoneal 14.5 mg/kg
Rat Subcutaneous 400 mg/kg
Mouse Subcutaneous 64 mg/kg

Benzalkonium chloride is a human skin and severe eye irritant.[38] It is a respiratory toxicant, immunotoxicant, gastrointestinal toxicant, and neurotoxicant.[39][40][41]

Benzalkonium chloride formulations for consumer use are dilute solutions. Concentrated solutions are toxic to humans, causing corrosion/irritation to the skin and mucosa, and death if taken internally in sufficient volumes. 0.1% is the maximum concentration of benzalkonium chloride that does not produce primary irritation on intact skin or act as a sensitizer.[42]

Poisoning by benzalkonium chloride is recognised in the literature.[43] A 2014 case study detailing the fatal ingestion of up to 8.1 oz (240 ml) of 10% benzalkonium chloride in a 78-year-old male also includes a summary of the currently published case reports of benzalkonium chloride ingestion. While the majority of cases were caused by confusion about the contents of containers, one case cites incorrect pharmacy dilution of benzalkonium chloride as the cause of poisoning of two infants.[44] In 2018 a Japanese nurse was arrested and admitted to having murdered approximately 20 patients at a hospital in Yokohama by injecting benzalkonium chloride into their intravenous drip bags.[45][46]

Benzalkonium chloride poisoning of domestic pets has been recognised as a result of direct contact with surfaces cleaned with disinfectants using benzalkonium chloride as an active ingredient.[47]

Biological activity

[edit]

The antimicrobial activity is dependent on the chain length. For example, yeast and fungi are most affected by C12, gram positive by C14, and gram negative by C16.[48]

The greatest biocidal activity is associated with the C12 dodecyl and C14 myristyl alkyl derivatives. The mechanism of bactericidal/microbicidal action is thought to be due to disruption of intermolecular interactions. This can cause dissociation of cellular membrane lipid bilayers, which compromises cellular permeability controls and induces leakage of cellular contents. Other biomolecular complexes within the bacterial cell can also undergo dissociation. Enzymes, which finely control a wide range of respiratory and metabolic cellular activities, are particularly susceptible to deactivation. Critical intermolecular interactions and tertiary structures in such highly specific biochemical systems can be readily disrupted by cationic surfactants.[citation needed]

Benzalkonium chloride solutions are fast-acting biocidal agents with a moderately long duration of action. They are active against bacteria and some viruses, fungi, and protozoa. Bacterial spores are considered to be resistant. Solutions are bacteriostatic or bactericidal according to their concentration. Gram-positive bacteria are generally more susceptible than gram-negative bacteria. Its activity depends on the surfactant concentration and also on the bacterial concentration (inoculum) at the moment of the treatment.[49] Activity is not greatly affected by pH, but increases substantially at higher temperatures and prolonged exposure times.

In a 1998 study using the FDA protocol, a non-alcohol sanitizer with benzalkonium chloride as the active ingredient met the FDA performance standards, while Purell, a popular alcohol-based sanitizer, did not. The study, which was undertaken and reported by a leading US developer, manufacturer and marketer of topical antimicrobial pharmaceuticals based on quaternary ammonium compounds, found that their own benzalkonium chloride-based sanitizer performed better than alcohol-based hand sanitizer after repeated use.[50]

Newer formulations using benzalkonium blended with various quaternary ammonium derivatives can be used to extend the biocidal spectrum and enhance the efficacy of benzalkonium based disinfection products.[citation needed] Formulation techniques have been used to great effect in enhancing the virucidal activity of quaternary ammonium-based disinfectants such as Virucide 100 to typical healthcare infection hazards such as hepatitis and HIV.[citation needed] The use of appropriate excipients can also greatly enhance the spectrum, performance and detergency, and prevent deactivation under use conditions.[citation needed] Formulation can also help minimise deactivation of benzalkonium solutions in the presence of organic and inorganic contamination.[citation needed]. However, recent studies have demonstrated the capacity of environmental microorganisms to develop reduced susceptibility to benzalkonium chloride by employing strategies such as modifying bacterial membranes: increasing pump activity, and reducing the expression of certain porins.[51]

Degradation

[edit]
Biodegradation pathways of BAC with Fenton process (H2O2/Fe2+)[52]

Benzalkonium chloride degradation follows consecutive debenzylation, dealkylation, and demethylation steps producing benzyl chloride, an alkyl dimethyl amine, dimethylamine, a long chain alkane, and ammonia.[52] The intermediates, major, and minor products can then be broken down into CO2, H2O, NH3, and Cl–. The first step to the biodegradation of BAC is the fission or splitting of the alkyl chain from the quaternary nitrogen as shown in the diagram. This is done by abstracting the hydrogen from the alkyl chain by using a hydroxyl radical leading to a carbon centered radical. This results in dimethylbenzylamine as the first intermediate and dodecanal as the major product.[52]

From here, dimethylbenzylamine can be oxidized to benzoic acid using the Fenton process. The trimethyl amine group in dimethylbenzylamine can be cleaved to form a benzyl that can be further oxidized to benzoic acid. Benzoic acid uses hydroxylation (adding a hydroxyl group) to form p-hydroxybenzoic acid. Dimethylbenzylamine can then be converted into ammonia by performing demethylation twice, which removes both methyl groups, followed by debenzylation, removing the benzyl group using hydrogenation.[52] The diagram[which?] represents suggested pathways of the biodegradation of BAC for both the hydrophobic and the hydrophilic regions of the surfactant. Since stearalkonium chloride is a type of BAC, the biodegradation process should happen in the same manner.

Regulation

[edit]

Benzalkonium chloride is classed as a Category III antiseptic active ingredient by the United States Food and Drug Administration (FDA). Ingredients are categorized as Category III when "available data are insufficient to classify as safe and effective, and further testing is required”.

In September 2016, the FDA announced a ban on nineteen ingredients in consumer antibacterial soaps citing a lack of evidence for safety and effectiveness.[53] A ban on three additional ingredients, including benzalkonium chloride, was deferred at that time to allow ongoing studies to be completed.

Benzalkonium chloride was deferred from further rulemaking in the 2019 FDA Final Rule on safety and effectiveness of consumer hand sanitizers, "to allow for the ongoing study and submission of additional safety and effectiveness data necessary to make a determination" on whether it met these criteria for use in OTC hand sanitizers, but the agency indicated it did not intend to take action to remove benzalkonium chloride-based hand sanitizers from the market.[54] There is acknowledgement that more data are required on its safety, efficacy, and effectiveness, especially with relation to:

  • Human pharmacokinetic studies, including information on its metabolites
  • Studies on animal absorption, distribution, metabolism, and excretion
  • Data to help define the effect of formulation on dermal absorption
  • Carcinogenicity
  • Studies on developmental and reproductive toxicology
  • Potential hormonal effects
  • Assessment of the potential for development of bacterial resistance
  • Risks of using it as a contraceptive method.

However, recent studies have demonstrated the capacity of environmental microorganisms to develop reduced susceptibility to benzalkonium chloride by employing strategies such as modifying bacterial membranes: increasing pump activity, and reducing the expression of certain porins.[55]

See also

[edit]

References

[edit]
  1. ^ "Zephiran (benzalkonium chloride)" (PDF). Sanofi. Retrieved 28 April 2020.
  2. ^ Maximilian Lackner, Josef Peter Guggenbichler "Antimicrobial Surfaces" Ullmann's Encyclopedia of Industrial Chemistry, Wiley-VCH, Weinheim, 2013. doi:10.1002/14356007.q03_q01
  3. ^ Bartlett, J (2013). Clinical Ocular Pharmacology (2 ed.). Elsevier. p. 20. ISBN 978-1-483-19391-5.
  4. ^ Ingredient indicated on Dial brand soap wrapper: "Benzalkonium chloride 0.10%". Henkel Corporation, Rocky Hill, CT 06067, USA. © 2018. Retrieved: 2023-06-06.
  5. ^ "Benzalkonium Chloride | Cosmetics Info". cosmeticsinfo.org. Archived from the original on 2020-11-01. Retrieved 2021-03-10.
  6. ^ "Bactine® Pain Relieving Cleansing Spray". dailymed.nlm.nih.gov. Retrieved 2020-03-04.
  7. ^ "Bactine Original First Aid Liquid, 4 fl oz Ingredients and Reviews". SkinSAFE. Retrieved 2020-03-04.
  8. ^ "Bradosol". Archived from the original on 2014-10-12. Retrieved 2013-05-20.
  9. ^ Ash, M; Ash, I (2004). Handbook of Preservatives. Synapse Info Resources. p. 286. ISBN 978-1-890-59566-1.
  10. ^ "Safety and Effectiveness for Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use (Final Rule)". U.S. Food and Drug Administration. 20 December 2017.
  11. ^ "Hand Hygiene Recommendations; Guidance for Healthcare Providers about Hand Hygiene and COVID-19". Centers for Disease Control and Prevention. 17 May 2020.
  12. ^ Ogilvie, Benjamin; Solis-Leal, Antonio (November 28, 2020). "Alcohol-free hand sanitizer and other quaternary ammonium disinfectants quickly and effectively inactivate SARS-CoV-2". Journal of Hospital Infection. 108: 142–145. doi:10.1016/j.jhin.2020.11.023. ISSN 0195-6701. PMC 7700010. PMID 33259880.
  13. ^ Hollingshead, Todd (December 1, 2020). "Alcohol-free hand sanitizer just as effective against COVID as alcohol-based versions". EurekAlert!. BRIGHAM YOUNG UNIVERSITY: AAAS. Retrieved December 14, 2020.
  14. ^ Bondurant, Sidney W.; Duley, Collette M.; Harbell, John W. (August 2019). "Demonstrating the persistent antibacterial efficacy of a hand sanitizer containing benzalkonium chloride on human skin at 1, 2, and 4 hours after application". American Journal of Infection Control. 47 (8): 928–932. doi:10.1016/j.ajic.2019.01.004. ISSN 1527-3296. PMID 30777389.
  15. ^ Reporter, JAMES ROSEN, Sinclair Investigative (2020-04-01). "EXCLUSIVE: Sanitizer opposed by CDC kills coronavirus "surrogate" in lab tests". WJLA. Retrieved 2021-03-16.{{cite web}}: CS1 maint: multiple names: authors list (link)
  16. ^ "Quats applications - Ophthalmics". 22 October 2021. Archived from the original on 2017-05-17.
  17. ^ Nelson, L; Goldfrank, L (2011). Goldfrank's Toxicologic Emergencies (9 ed.). McGraw-Hill Medical. p. 803. ISBN 978-0-071-60593-9.
  18. ^ Baudouin, C; Creuzot-Garcher, C; Hoang-Xuan, T (2001). Inflammatory Diseases of the Conjunctiva (1, illustrated ed.). Thieme. p. 141. ISBN 978-3-131-25871-7.
  19. ^ Otten, Mary; Szabocsik, John M. (1976). "Measurement of Preservative Binding with SOFLENS (polymacon) Contact Lens". Clinical and Experimental Optometry. 59 (8): 277. doi:10.1111/j.1444-0938.1976.tb01445.x.
  20. ^ M Akers, "Consideration in selecting antimicrobial preservative agents for parenteral product development", Pharmaceutical Technology, May, p. 36 (1984).
  21. ^ US 5827870, Chodosh, Daniel Frank, "Antimicrobial compositions and methods for using the same", published 1998-10-27, assigned to Woodward Laboratories Inc. 
  22. ^ JP 5047476, Wu, Jeffrey M.; Liu, Jue-Chen & Chantalat, Jeanette et al., "Composition containing anti-acne agent and method of using the same", published 2012-10-10, assigned to Johnson & Johnson 
  23. ^ Farley, Susan (June 2006). "New Combination Acne Treatment Safe and Effective". Pharmacy Times. Retrieved 2021-03-10.
  24. ^ "Benzalkonium Chloride - Contraception formulations". 22 October 2021. Archived from the original on 2017-05-15.
  25. ^ "ISRCTN - ISRCTN16203579: Effectiveness of BenZalKonium chloride gel as vaginal contraceptive: a multicentric randomised controlled trial". www.isrctn.com.
  26. ^ Li, Weihua; Huang, Zirong; Wu, Yu; Wang, Haiyun; Zhou, Xiaobo; Xia o, Zhiqin; Ding, Xuncheng; Xu, Jinxun (June 26, 2013). "Effectiveness of an optimized benzalkonium chloride gel as vaginal contraceptive: a randomized controlled trial among Chinese women". Contraception. 87 (6): 756–765. doi:10.1016/j.contraception.2012.09.012. PMID 23089047.
  27. ^ "БЕНЗАЛКОНИЯ ХЛОРИД (benzalkonium chloride) действующее вещество | 36i6.info". 36i6.info (in Russian). 2017-04-15. Archived from the original on 2019-08-28. Retrieved 2019-08-28.
  28. ^ Baudouin, C; Labbé, A; Liang, H; Pauly, A; Brignole-Baudouin, F (2010). "Preservatives in eyedrops: the good, the bad and the ugly". Prog Retin Eye Res. 29 (4): 312–34. doi:10.1016/j.preteyeres.2010.03.001. PMID 20302969. S2CID 24575844.
  29. ^ Goldstein MH, Silva FQ, Blender N, Tran T, Vantipalli S (February 2022). "Ocular benzalkonium chloride exposure: problems and solutions". Eye (Lond). 36 (2): 361–368. doi:10.1038/s41433-021-01668-x. PMC 8277985. PMID 34262161.
  30. ^ a b Kennedy, D W; Bolger, W E; Zinreich, S J (2001). Diseases of the Sinuses Diagnosis and Management. B.C. Decker Inc. p. 162. ISBN 978-1-550-09045-1.
  31. ^ Marple, B; Roland, P; Benninger, M (2004). "Safety review of benzalkonium chloride used as a preservative in intranasal solutions: an overview of conflicting data and opinions". Otolaryngology–Head and Neck Surgery. 130 (1): 131–41. doi:10.1016/j.otohns.2003.07.005. PMID 14726922. S2CID 24967410.
  32. ^ Beule, A. G. (2010). "Physiology and pathophysiology of respiratory mucosa of the nose and the paranasal sinuses". GMS Current Topics in Otorhinolaryngology, Head and Neck Surgery. 9: Doc07. doi:10.3205/cto000071. PMC 3199822. PMID 22073111.
  33. ^ Graf, P (2005). "Rhinitis medicamentosa: a review of causes and treatment". Treatments in Respiratory Medicine. 4 (1): 21–9. doi:10.2165/00151829-200504010-00003. PMID 15725047. S2CID 25175067.
  34. ^ Snow, J. B.; Wackym, P. A. (2009). Ballenger's Otorhinolaryngology: Head and Neck Surgery (revised ed.). PMPH-USA. p. 277. ISBN 978-1-550-09337-7.
  35. ^ Malo, J; Chan-Yeung, M; Bernstein, D I (2013). Asthma in the Workplace (4, illustrated, revised ed.). CRC Press. p. 198. ISBN 978-1-842-14591-3.
  36. ^ Gerald, Lynn B; Gerald, Joe K; McClure, Leslie A; Harrington, Kathy; Erwin, Sue; Bailey, William C (2011). "Redesigning a large school-based clinical trial in response to changes in community practice". Clinical Trials: Journal of the Society for Clinical Trials. 8 (3): 311–319. doi:10.1177/1740774511403513. ISSN 1740-7745. PMC 3145214. PMID 21730079.
  37. ^ "RTECS BO3150000 Ammonium, alkyldimethylbenzyl - , chloride". 28 March 2018.
  38. ^ Lewis R J Sr (2004). Lewis, Richard J (ed.). Sax's Dangerous Properties of Industrial Materials (11 ed.). Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. p. 104. doi:10.1002/0471701343. ISBN 978-0471701347. SAFETY PROFILE: Poison by ingestion. Moderately toxic by skin contact. A severe eye irritant. A bactericide and fungicide. Dangerous; when heated to decomposition it emits toxic fumes of Cl- and NOx.
  39. ^ "TOXNET Benzalkonium Chloride Compounds".
  40. ^ "Haz-Map Benzalkonium Chloride". Archived from the original on 2014-10-06. Retrieved 2014-11-11.
  41. ^ "NIOSH ICSC Benzalkonium Chloride". Archived from the original on 2017-11-16. Retrieved 2017-09-08.
  42. ^ Seymour Stanton Block (2001). Disinfection, sterilization, and preservation (5, illustrated ed.). Lippincott Williams & Wilkins. p. 311. ISBN 978-0-683-30740-5.
  43. ^ Dart, R C (2004). Medical Toxicology (illustrated, revised ed.). Lippincott Williams & Wilkins. p. 125. ISBN 978-0-781-72845-4.
  44. ^ Gossel, T A (1994). Principles Of Clinical Toxicology, Third Edition (3, illustrated, revised ed.). CRC Press. ISBN 9780781701259.
  45. ^ Adelstein, Jake (2018-09-01). "Examining the motives behind mass murder in Japan". The Japan Times. Retrieved 2020-08-04.
  46. ^ Ryall, Julian (2018-07-10). "Japanese nurse investigated over 20 killings at end of shifts to avoid 'nuisance' of telling families of deaths". The Telegraph. ISSN 0307-1235. Retrieved 2018-08-26.
  47. ^ Campbell, A; Chapman, M (2008). Handbook of Poisoning in Dogs and Cats. John Wiley & Sons. p. 17. ISBN 978-0-470-69844-0.
  48. ^ Daoud, N. N.; Dickinson, N. A.; Gilbert, P. (1983). "Antimicrobial activity and physico-chemical properties of some alkyldimethylbenzylammonium chlorides". Microbios. 37 (148): 73–85. ISSN 0026-2633. PMID 6413825.
  49. ^ García, MR; Cabo, ML (June 2018). "Optimization of E. coli Inactivation by Benzalkonium Chloride Reveals the Importance of Quantifying the Inoculum Effect on Chemical Disinfection". Frontiers in Microbiology. 9: 1259. doi:10.3389/fmicb.2018.01259. PMC 6028699. PMID 29997577.
  50. ^ Closed access icon Dyer, David L.; Gerenratch, Kenneth B.; Wadhams, Peter S. (1998). "Testing a New Alcohol-Free Hand Sanitizer to Combat Infection". AORN Journal. 68 (2): 239–251. doi:10.1016/s0001-2092(06)62517-9. ISSN 0001-2092. PMID 9706236.
  51. ^ Chacón, Luz; Kuropka, Benno; González-Tortuero, Enrique; Schreiber, Frank; Rojas-Jiménez, Keilor; Rodríguez-Rojas, Alexandro (2023-06-02). "Mechanisms of low susceptibility to the disinfectant benzalkonium chloride in a multidrug-resistant environmental isolate of Aeromonas hydrophila". Frontiers in Microbiology. 14. Frontiers Media SA: 1180128. doi:10.3389/fmicb.2023.1180128. ISSN 1664-302X. PMC 10272739. PMID 37333642.
  52. ^ a b c d Rowe, Raymond (2009). Handbook of Pharmaceutical Excipients 6th Edition. London, UK: Pharmaceutical Press. pp. 56–58. ISBN 978-1-58212-135-2.
  53. ^ "Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use". 2016-09-06. Retrieved 2016-10-05.
  54. ^ "FDA issues final rule on safety and effectiveness of consumer hand sanitizers". United States Food and Drug Administration. Retrieved 23 March 2020.
  55. ^ Chacón L, Kuropka B, González-Tortuero E, Schreiber F, Rojas-Jiménez K and Rodríguez-Rojas A (2023) Mechanisms of low susceptibility to the disinfectant benzalkonium chloride in a multidrug-resistant environmental isolate of Aeromonas hydrophila. Front. Microbiol. 14:1180128. doi: 10.3389/fmicb.2023.1180128

Further reading

[edit]
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Benzalkonium_chloride&oldid=1232551221"